文章基本信息

标题：Perfil clínico, epidemiológico e laboratorial de pacientes portadores de Síndromes Respiratórias Agudas Graves (SRAGs) e COVID-19, admitidos em um Hospital Universitário da regio do submédio do So Francisco
本地全文：下载
作者：July Martins de Oliveira ; Ian Mazzetti Rodrigues Valle ; Carine Rosa Naue 等
期刊名称：Research, Society and Development
电子版ISSN：2525-3409
出版年度：2021
卷号：10
期号：16
页码：1-12
DOI：10.33448/rsd-v10i16.23691
语种：English
出版社：Grupo de Pesquisa Metodologias em Ensino e Aprendizagem em Ciências
摘要：Severe Acute Respiratory Syndromes (SARS) can be defined by the presence of fever, cough (or sore throat) and dyspnoea, or reduction in O2 saturation. Although they have many etiologies, during the 2020 pandemic occurred a significant increase in the reported cases resulting from infections by SARS-CoV-2. The present study aims to describe the clinical, epidemiological and laboratory data of patients admitted to the University Hospital of the Federal University of Vale do So Francisco with suspected SARS due to COVID-19 or unspecified. This is a retrospective, observational cross-sectional study, with a sample of 72 individuals, admitted between March and July 2020. Data were collected from electronic medical records. For data analysis, simple and relative frequencies were calculated and statistical analysis were performed using SPSS. Most individuals were male and had an average age of approximately 57 years. Regarding comorbidity 86.11% had at least one. The most prevalent being hypertension, advanced age and metabolic disorders. Fever, reduced O2 saturation and dyspnoea were the most common symptoms among the 47 patients infected with SARS-CoV-2. High levels of TGO, D-dimer and ferritin, as well as a reduction in the rates of albumin and hemoglobin were the most common laboratory alterations. Furthermore, 74.5% required mechanical ventilation, and the major outcome was death. The data described are able to help clinical practice, as they show the most frequent findings observed in individuals with SARS.
关键词：COVID-19;Severe Acute Respiratory Syndrome;Signs and symptoms.